Nine Square Therapeutics

Nine Square Therapeutics is a developer of novel therapies for movement disorders based in San Francisco, California, USA. The company will integrate computational chemistry, biophysics, and computational biology into machines to discover new small-molecule therapies for degenerative movement disorders, including Parkinson's disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative conditions such as essential tremor and dyskinesia. A cell profiling platform with learning capabilities can be used for target identification, chemical optimization, and patient stratification. The company originated from a collaboration between ATP and scientists at the University of California, San Francisco (UCSF).